{"name":"Origo Biopharma","slug":"origo-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPQmFIRVZ4VFhhQUNLU2pocGVCWUZPNkVIdjdtanZNMVlCUmNwWXdwejRSbWJkQmtuY2JoaEFXekQ3eW82WTFiOWhJQTBoVlBXZGNCMkJ1RExFUGFOX1pLT0ZVZEY5MWNFMVNUQUhHc1NvczByTWYxUVBERV81Q1NmcVFSSGp4b1NndjQ4eXlR?oc=5","date":"2026-02-06","type":"pipeline","source":"fiercebiotech.com","summary":"Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M - fiercebiotech.com","headline":"Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQdC1iNDVGT2hra19TQmtkcGZWbmh1Sk0yMjdiaWoxcGh4bEY0SjdTcjFMTnJYZlVfdjZKMXc2RDY4enlnaDkwLXl3R3V4amRvS0s1ZGtSQTlaYzgzZXU1NEY1LVFERDJNQjlUaHMtYlBTSHA3QS1fVFhXYkJRNXNvZjhOX1hxLVlUbnNYYkxUdldyWkFsZUhaRTdOWFBtVjE0REQ5RTYycw?oc=5","date":"2026-01-19","type":"pipeline","source":"fiercebiotech.com","summary":"Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions - fiercebiotech.com","headline":"Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbGdvVFdOQkQyQ016WmtQQ2ZTRU81cWE1VnFFNnFMd2t5bU41Nzh6UURXcVk1YkRHWGkxYlFsMzU1U3VKYnBobGgxSUNBRXZ2VmZiaXhqUnRsclhZbTBIVURxSlF0UmZDM3I4R2E2M0pqcUdSRTdDdDlJdi16QjBCZWU2SzJlalVnXzd1M2kyVFVBaDZ0Rmp1ZlBDeEUtY0FSOHUzN1hiSjAtSWdXN1NWQnZDTE9nbXJGb1VSUkdEQmJFV1ZTcTRkb3lVMVFkcWJyM1ljQTBYSWh1M3BwaTBoMFFVYWJuRHNTYlNjNA?oc=5","date":"2025-04-15","type":"pipeline","source":"PR Newswire UK","summary":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK","headline":"Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPM0VKOVhxemRlcGRGV2pKbXR5ZzRFRXJJMHU4bVZXcGlTY2h3enFqenZHNzYwb3d2ZHRRaTFFeDIwZ3QxTy1KdTNrLXFjMEJKeWdWU0Z3U1IwZnNIc3NVbUwyamNBSVJ5d2hZN2JhOE5MR3hpR0djY193TVZMaUJkS0h6eXdrakhoRnIyeGoyM0lTczVEWl93Zjh5WnRzX0xLMWlsMnNsc0RDUGU2S0FvT0N4VEo1dw?oc=5","date":"2025-03-10","type":"trial","source":"fiercebiotech.com","summary":"Agomab's ALK5 inhibitor hits target in phase 2 Crohn's disease trial - fiercebiotech.com","headline":"Agomab's ALK5 inhibitor hits target in phase 2 Crohn's disease trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOWmpLUEs1YXRPY0VSMVh0MkhDNzBvZlJfM1FsLWVnTzJ3cThIT2FiXzlOZXlLT0w5eHF1ZnJGSEtWQkdELUdkdjV0Z0JCY09vWkZJb01CWHJiYmNfRnNwOVdhb1dLUWExaEJNcTRib3I3bWRjY2IzaXpxRFpLNmZ0VUVnTV84THlldlYyTg?oc=5","date":"2024-10-25","type":"pipeline","source":"The Pharma Letter","summary":"Agomab secures $89 million Series D financing - The Pharma Letter","headline":"Agomab secures $89 million Series D financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNc0syVWhkYnNhMFVHRTJxQkR4SjlsUE13VjVndUpwUnFVQVpTNF9xUFppckVVa3plMFFfd2FmdUdaRjRwR3ltR0lvSmlJZzdvY3h0RWdtZ2t2NXVpUkxOdml1dS1ZRGluemtOYXFUNTg2aDd2ZWNVX1drdHN1eGVPWkwtRQ?oc=5","date":"2024-10-16","type":"pipeline","source":"MedPage Today","summary":"Novel Drug Maintained Clinical Improvements in IBD - MedPage Today","headline":"Novel Drug Maintained Clinical Improvements in IBD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNemRXMXdubFhLX2ktWlhUUEtMNzRaQVA3djVjbWhsSVV2RFlqT2pVUWtfZWVHRkQ1Q1JVNE1PWUJNUjY4cmg2czN6R0VabjIxZFF4RWxqeHFxeUpQYk5YcmlCQjg2cnZReDFia3pxVjIwY1pEakhEbW5oZDdQMmpfRExOWHFONDZhVDZsY3hZeGJRdmkzWnV0TmJwZ1VKVng1akpqMXRqWEVGdnV0dUE4dXpHX25WODN5YUl2YmRtcDlTOFNjbGRnQTN3cUFGM21jVmc?oc=5","date":"2022-10-24","type":"pipeline","source":"Healio","summary":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC - Healio","headline":"Higher-dose upadacitinib reduces disease severity, prolongs clinical remission in UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxORzdKVngwbE9CT0ZILTh2czRHNS1zSVFub2Vsb05VZUt1VFRscjVibGJZYUtkSC1KWlF3aTZMeTd1U29KbHU2WW9YMGZlQ2I1NV9SU3dnWXhzcjc5Y0JBUm0tWXpWLVhxb093OGxJVFRoZl9iQkQ5T3J3U2lFSklxUnUyYXdEYzYzRGNCM2hYTnpGdndDbWc?oc=5","date":"2022-08-03","type":"pipeline","source":"Business Insider","summary":"See the 21-slide pitch deck a biotech startup used to convince investors like Pfizer to bet on fixing damaged organs - Business Insider","headline":"See the 21-slide pitch deck a biotech startup used to convince investors like Pfizer to bet on fixing damaged organs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdG01U3JJd2Uxc2x5Zm1DbncwZVNFdkZWOEtQZHNZaHlNTnVrNkY0cUNyY3NXUm41aXYyQmFTenNEMnhCVk1MTEFlUGgtUFVBdXJRbUt5ekR0SVNXYkNleS14ZHJ6SjBpMmNWMlN0NVh1TVpvS3o5UHRteWVKeUdmNXFRM3BmUENpMERRMmRZejV5WFU2NGRKUXctX0JvazFlV25ZTDRScUY2TkxjOWFpakFHSndGblNaamtMY1FPNTU?oc=5","date":"2022-07-13","type":"pipeline","source":"fiercebiotech.com","summary":"Pfizer jumps into bed with Agomab, leading series B extension and lending support to Crohn's program - fiercebiotech.com","headline":"Pfizer jumps into bed with Agomab, leading series B extension and lending support to Crohn's program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOMUZlRDQtbzVxTU9HVnltUjFZOXlNdUFqV3FvMG5EaDZ4QUFINzVhNlktMllxQkVhUUhLZXJVRHB5TktIWGNrYXB1T1VYdDhaLWlJVEQtUTdid056aW1CdFNDTHhrMDdUTUpTQzFsR29zRExDWURUelo1N0Z5NTFOZm9wSGtmV2xXVENSZWhGNUI?oc=5","date":"2021-06-26","type":"pipeline","source":"EU-Startups","summary":"101 Top Biotechnology Startups and Companies in Spain (2021) - EU-Startups","headline":"101 Top Biotechnology Startups and Companies in Spain (2021) - EU","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}